Inverness Counsel’s Eli Lilly LLY Stock Holding History

Inverness Counsel’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$562K	Buy	1,739 +51	+3%	+$16.2K	0.03%	116
2022 Q2	$547K	Sell	1,688 -80	-5%	-$24K	0.03%	114
2022 Q1	$506K	Buy	1,768 +12	+0.7%	+$3.09K	0.02%	124
2021 Q4	$485K	Sell	1,756 -12	-0.7%	-$3.04K	0.02%	122
2021 Q3	$408K	Buy	1,768 +12	+0.7%	+$2.96K	0.02%	134
2021 Q2	$403K	Hold	1,756	–	–	0.01%	126
2021 Q1	$328K	Sell	1,756 -200	-10%	-$39.1K	0.01%	124
2020 Q4	$330K	Hold	1,956	–	–	0.01%	116
2020 Q3	$290K	Hold	1,956	–	–	0.01%	115
2020 Q2	$321K	Sell	1,956 -174	-8%	-$26.7K	0.02%	103
2020 Q1	$295K	Hold	2,130	–	–	0.02%	99
2019 Q4	$280K	Hold	2,130	–	–	0.01%	105
2019 Q3	$238K	Sell	2,130 -1,265	-37%	-$141K	0.01%	108
2019 Q2	$376K	Sell	3,395 -475	-12%	-$55.9K	0.02%	87
2019 Q1	$502K	Sell	3,870 -26,040	-87%	-$3.17M	0.03%	80
2018 Q4	$3.46M	Buy	29,910 +27,255	+1,027%	+$3.04M	0.23%	53
2018 Q3	$285K	Buy	2,655 +309	+13%	+$30.9K	0.02%	112
2018 Q2	$200K	Buy	+2,346	New	+$193K	0.01%	125

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Inverness Counsel's LLY Position: Q3 2022 in Review

Inverness Counsel increased its Eli Lilly (LLY) stake by 3% in Q3 2022, buying an estimated $16.2K and bringing the position to 1,739 shares worth $562K. The position accounts for 0.03% of the portfolio, ranked #116.

Inverness Counsel first reported a position in LLY in Q2 2018 and has held it in 18 quarters since. The position peaked at $3.46M in Q4 2018. 2,485 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

Inverness Counsel held 1,739 shares of Eli Lilly worth $562K as of Q3 2022.
Inverness Counsel bought 51 Eli Lilly shares in Q3 2022, an estimated $16.2K.
Eli Lilly made up 0.03% of Inverness Counsel's portfolio in Q3 2022, its #116 holding.
Inverness Counsel first reported a position in Eli Lilly in Q2 2018 and has held it in 18 quarters since.
Inverness Counsel's Eli Lilly position peaked at $3.46M in Q4 2018.
2,485 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.